Faria Rita, Melica Bruno, Pires-Morais Gustavo, Rodrigues Alberto, Ribeiro José, Guerra Miguel, Gama Vasco, Vouga Luís
Serviço de Cardiologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Serviço de Cardiologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
Rev Port Cardiol. 2014 Jul-Aug;33(7-8):469.e1-5. doi: 10.1016/j.repc.2014.02.015. Epub 2014 Aug 8.
Ischemic cardiomyopathy is the leading cause of heart failure. In patients with left ventricular (LV) dilatation, low ejection fraction, and transmural scar in an anteroseptal distribution, surgical ventricular reconstruction (SVR) is a treatment option. We describe our first experience with the Less Invasive Ventricular Enhancement (LIVE) technique using the Revivent™ system (Bioventrix Inc., San Ramon, CA), in the treatment of a large anteroapical aneurysm.
缺血性心肌病是心力衰竭的主要原因。对于左心室(LV)扩张、射血分数低且前间隔分布有透壁瘢痕的患者,手术心室重建(SVR)是一种治疗选择。我们描述了我们首次使用Revivent™系统(Bioventrix公司,加利福尼亚州圣拉蒙)的微创心室增强(LIVE)技术治疗巨大心尖前壁动脉瘤的经验。